EUDAMED, GUDID or MHRA: Route a Device Registration Request by Market
Use EUDAMED for EU and most Northern Ireland device records, GUDID for US UDI data, and MHRA registration for the Great Britain market.
Signals to watch
- A manufacturer names a launch or distributor deadline but says only device registration or UDI database
- The destination market, legal manufacturer, responsible representative or device identifier is missing
- A team cites an EUDAMED, GUDID or MHRA record as proof of approval beyond that system’s stated scope
Route the request by destination market first, then operator and record object. Use EUDAMED when the task concerns the EU medical-device database or, under current UK guidance, most devices placed on the Northern Ireland market. Use GUDID when a US labeler must submit or correct Unique Device Identification data. Use the MHRA Device Online Registration System when a manufacturer or UK Responsible Person must register a device for the Great Britain market.
The database name is often the least reliable part of the request
These systems are not interchangeable, and none is a universal approval database. A medical-device regulatory service business-development lead needs that distinction when authorised manufacturer, distributor and regulatory-affairs Telegram groups contain fragments such as “need the device database fixed before launch.” If the destination market remains unknown until the next day, the request may already have been sent to the wrong regional specialist while a distributor or launch review continues.
The following is an illustrative composite, not a real manufacturer, device or commercial result:
“Need UDI registration sorted for UK and Europe. US file is there already.”
“Distributor says the database record has to match before Friday.”
The messages do not identify whether “UK” means Great Britain or Northern Ireland, whether “Europe” means an EU market, which legal manufacturer owns the record, which representative acts for it, or whether the US file is a GUDID Device Identifier record or a premarket submission. They also do not show the device class, identifier, certificate route or sender’s authority.
The first useful question is therefore not “Which database login do you have?” It is “In which market will this exact device first be placed, and which record is blocking that event?”
One destination field chooses the first official source
| Destination and request | First system to open | Record owner or submitter | What the record can establish | What it cannot establish alone |
|---|---|---|---|---|
| EU market, or most Northern Ireland devices after 28 May 2026 | EUDAMED | Applicable economic operator, notified body or authority by module | Actor, device/UDI, certificate or surveillance data in the applicable module | Complete conformity, lawful placement or a national exception |
| United States UDI data | GUDID | Device labeler | Device Identifier data and public label-related attributes | FDA clearance, approval, establishment registration or every production identifier |
| Great Britain market | MHRA device registration | UK manufacturer or UK Responsible Person for an overseas manufacturer | Registration of the manufacturer/device route for Great Britain | Accreditation, certification, approval or endorsement |
This table routes the first source. It does not replace a regulatory assessment. A product can require several records, and the responsible operator may need to involve a notified body, approved body, authorised representative, UK Responsible Person or authority.
EUDAMED starts with the EU object and economic-operator role
EUDAMED is the European database on medical devices. The European Commission overview says its first four modules became mandatory on 28 May 2026: Actor Registration, UDI/Device Registration, Notified Bodies and Certificates, and Market Surveillance. The last of those is used by competent authorities and the Commission. The two remaining modules were still under development on the page accessed on 18 August 2026.
An EUDAMED request must name the module and object. An actor problem concerns the economic operator and its Single Registration Number. A UDI/device problem concerns product identity and the relationship between a Basic UDI-DI, Device Identifier and responsible actor. A certificate problem may depend on a notified body. “Registered in Europe” hides these different owners.
Northern Ireland makes the geographic question especially important. The MHRA registration guidance, updated 20 July 2026, says that from 28 May 2026 medical devices other than custom-made devices must be registered in EUDAMED before placement on the EU and Northern Ireland markets. The same guidance keeps a separate MHRA route for custom-made devices in Northern Ireland. The exact device and market route must be checked before anyone assumes that one UK database covers both territories.
For an object-level EUDAMED repair, the EUDAMED actor, device and certificate handoff explains how to separate those records. This page answers the earlier navigation question: which regional source should be opened first.
GUDID answers the US Device Identifier data question
GUDID is the Global Unique Device Identification Database administered by the US Food and Drug Administration. FDA describes it as a reference catalog for devices with a Unique Device Identifier and says it contains the Device Identifier portion, not the production identifiers themselves. Labelers can submit data through the web application for individual records or through the FDA Electronic Submissions Gateway for bulk records.
That makes GUDID the right starting point when a US request concerns a Device Identifier, labeler, model identity or public AccessGUDID record. It is not the right source for every sentence containing “FDA.” A GUDID match does not prove that FDA cleared or approved a device. It also does not establish the current registration of an establishment.
The distinction matters in intake. Ask for the exact Device Identifier, labeler name, device version/model and the GUDID response. If the business question is instead about a 510(k) decision or an establishment listing, route it to the appropriate FDA record. The FDA device-record source navigator separates 510(k), AccessGUDID and Registration & Listing claims.
MHRA registration is the Great Britain route
Great Britain means England, Wales and Scotland. MHRA guidance says all medical devices, including in vitro diagnostic and custom-made devices, must be registered with the MHRA before they can be placed on the Great Britain market. Where the manufacturer is outside the UK, it must appoint one UK Responsible Person to take responsibility for all its devices, and that person handles registration responsibilities for the manufacturer.
The same official page states a boundary that should appear in every commercial intake note: MHRA registration is not accreditation, certification, approval or endorsement. A visible record can support a registration statement for the named market route. It cannot support a broader claim that MHRA approved the product.
Ask which legal manufacturer owns the device, whether a UK Responsible Person is appointed, which legislation and device class apply, and which device identifiers and conformity documents support the record. If a request mentions Northern Ireland, stop treating it as a Great Britain registration until the applicable Northern Ireland route is confirmed.
The six-field routing card prevents a regional handoff failure
Before assigning an EU, US or UK specialist, capture six fields:
- Destination market: EU member state, United States, Great Britain or Northern Ireland.
- Planned event and date: first placement, distributor review, label-data correction or another named event.
- Legal operator: manufacturer, labeler, authorised representative, UK Responsible Person, importer, notified body or authority.
- Device identity: device name, version/model, class and stable identifier such as Basic UDI-DI, UDI-DI or GUDID DI where applicable.
- Exact record and response: module, database, record ID, validation message or dated screenshot with its source URL.
- Unresolved decision: the fact the business still needs a qualified person to decide.
A routing card is complete when another reviewer can reproduce why the request went to one system and see which facts remain unverified. It is not complete merely because the word “registration” appears beside a market name.
Early discovery can preserve the route without deciding it
TOP Prospect can help a regulatory service lead find and group these fragments in Telegram groups the user deliberately connects and is authorised to access. It can preserve the source, time and wording and rank a candidate for review. The current production matching-target interface saves the user’s configuration but does not yet automatically create new candidates. The product cannot identify the legal manufacturer from an ambiguous name, enter a regulator database, decide the applicable law, contact the writer or certify a device.
When a forwarded database claim has lost its original URL, use the official-source verification ladder before copying it into an intake note. The route becomes commercially useful only after the human reviewer confirms the market, operator and object.
Key facts
- The first four EUDAMED modules became mandatory on 28 May 2026; that statement does not mean every EUDAMED module is complete.
- Current MHRA guidance sends Great Britain device registration to the MHRA route and most Northern Ireland device registration to EUDAMED, with a separate treatment for custom-made devices.
- GUDID contains Device Identifier data submitted by labelers; it is not the FDA premarket-decision or establishment-registration database.
- MHRA expressly says registration does not represent approval, certification, accreditation or endorsement.
- Destination, operator and record object must be known before the database name can be treated as a service scope.
FAQ
Is EUDAMED the right starting point for every European device request?
No. It is the EU medical-device database and, since 28 May 2026, its first four modules are mandatory. Great Britain uses MHRA registration, while Northern Ireland follows EUDAMED for devices other than custom-made devices under current MHRA guidance.
Does a GUDID record prove FDA clearance or approval?
No. GUDID is the FDA-administered reference catalog for the Device Identifier portion of a Unique Device Identifier. Premarket decisions and establishment records belong to other FDA sources.
Does MHRA registration approve a device?
No. MHRA states that device registration is not accreditation, certification, approval or endorsement. It is a registration record for the applicable UK market route.
What should a regulatory service provider ask before assigning a specialist?
Ask for destination market, legal manufacturer and representative, device class and status, exact record object, stable identifier, current official response and the dated business event the record must support.
Reviewed by TOP Prospect Editorial Team on 18 August 2026. Source routing was checked against the European Commission, FDA and MHRA pages listed above. Device classification, market placement, representative appointment and submission duties require qualified review of the actual facts.
Frequently asked questions
Is EUDAMED the right starting point for every European device request?
No. It is the EU medical-device database and, since 28 May 2026, its first four modules are mandatory. Great Britain uses MHRA registration, while Northern Ireland follows EUDAMED for devices other than custom-made devices under current MHRA guidance.
Does a GUDID record prove FDA clearance or approval?
No. GUDID is the FDA-administered reference catalog for the Device Identifier portion of a Unique Device Identifier. Premarket decisions and establishment records belong to other FDA sources.
Does MHRA registration approve a device?
No. MHRA states that device registration is not accreditation, certification, approval or endorsement. It is a registration record for the applicable UK market route.
What should a regulatory service provider ask before assigning a specialist?
Ask for destination market, legal manufacturer and representative, device class and status, exact record object, stable identifier, current official response and the dated business event the record must support.
Sources and further reading
How a Signal worth attention is found
See how Top Prospect finds and organizes Signals worth checking, keeps the original Telegram context, removes duplicates, and helps you decide what to review first. You decide whether to follow up and what to do next.
